The Business Case: Cost Savings and Patient Hesitancy
Dr. Lindsey Jennings talks about how giving buprenorphone in the ED provides significant cost savings per patient, and decreases the likelihood that they will die from their OUD.
Join the Code Recover Network
*By clicking "Sign up", you consent to receive periodic updates from Mobilize Recovery by email, text and/or phone. You can unsubscribe or text STOP at any time. Message and data rates may apply.
Featured Clinician Resources
Other Related Resources
- Cost and Cost-Savings of Navigation Services to Avoid Re-hospitalization (NavSTAR) for a Comorbid Substance Use Disorder Population - PMC
- Navigation Services to Avoid Rehospitalization among Medical/Surgical Patients with Comorbid Substance Use Disorder: Rationale and Design of a Randomized Controlled Trial
- Emergency Department Peer Support Program and Patient Outcomes After Opioid Overdose | Clinical Pharmacy and Pharmacology | JAMA Network Open
- Plus 14 more
